BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Virios Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  Virios Therapeutics, Inc. today announced that it will report first quarter 2023 financial results on Thursday, May 11, 2023 before the open of the financial markets.

  May 4, 2023

   · 

  3 min read
• Pharm Country

  BioRestorative Therapies, Inc. to participate at the EF Hutton Global Conference May 10-11 in New York City

  BioRestorative Therapies, Inc. today announced that CEO Lance Alstodt will participate at the Inaugural EF Hutton Global Conference taking place May 10th to 11th at the Plaza Hotel in New York City.

  May 4, 2023

   · 

  3 min read
• Business

  Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update

  Kymera Therapeutics, Inc. today reported business highlights and financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  17 min read
• Pharm Country

  Passage Bio Announces Recipient of Second Annual Tachi Yamada Scholarship Award

  Passage Bio, Inc. has announced Nicolette “Nikki” Evich, a sophomore at The Schreyer Honors College at The Pennsylvania State University, as the second recipient of its Tachi Yamada Scholarship award.

  May 4, 2023

   · 

  3 min read
• FDA

  Tonix Pharmaceuticals Announces IND Clearance for TNX-1500 (anti-CD40L mAb) for the Prevention of Organ Rejection in Patients Receiving a Kidney Transplant

  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to support a Phase 1 clinical trial with TNX-1500 (anti-CD40L monoclonal antibody [mAb]).

  May 4, 2023

   · 

  7 min read
• Business

  Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

  Omega Therapeutics today announced financial results for the first quarter ended March 31, 2023, and highlighted recent Company progress.

  May 4, 2023

   · 

  10 min read
• FDA

  Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE

  Optinose today announced the U.S. Food and Drug Administration (FDA) accepted for review its supplemental new drug application (sNDA) requesting approval of XHANCE as a treatment for chronic rhinosinusitis.

  May 4, 2023

   · 

  8 min read
• Business

  Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

  Surface Oncology today reported financial results and corporate highlights for the first quarter 2023, as well as anticipated near-term milestones.

  May 4, 2023

   · 

  8 min read
• Pharm Country

  GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

  GeneDx announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing tests with buccal swabs as an alternative sample collection option for biological parents or other immediate family members.

  May 4, 2023

   · 

  3 min read
• Business

  Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update

  Chimerix today reported financial results for the first quarter ended March 31, 2023 and provided an operational update.

  May 4, 2023

   · 

  9 min read